TS
Tejas Savant Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
TEM
1
Tempus AI, Inc. Class A Common Stock
TEM
$14.1B
| $81.01 | $68 |
16%
downside
| Overweight |
12 Aug ‘25
28 days ago |
|
2
10x Genomics
TXG
$1.68B
| $13.50 | $17 |
26%
upside
| Overweight |
12 Aug ‘25
28 days ago |
|
3
Illumina
ILMN
$15.1B
| $98.22 | $105 |
7%
upside
| Equal-Weight |
4 Aug ‘25
1 month ago |
|
4
Avantor
AVTR
$8.75B
| $12.83 | $12 |
6%
downside
| Equal-Weight |
4 Aug ‘25
1 month ago |
|
5
Hologic
HOLX
$14.8B
| $66.72 | $69 |
3%
upside
| Equal-Weight |
31 Jul ‘25
1 month ago |
|
6
NeoGenomics
NEO
$1.02B
| $7.86 | $8 |
2%
upside
| Equal-Weight |
30 Jul ‘25
1 month ago |
|
7
Cytek Biosciences
CTKB
$500M
| $3.93 | $7 |
78%
upside
| Equal-Weight |
28 May ‘25
3 months ago |
|
8
CryoPort
CYRX
$493M
| $9.85 | $7 |
29%
downside
| Equal-Weight |
5 May ‘25
4 months ago |
|
9
Adaptive Biotechnologies
ADPT
$1.92B
| $12.61 | $9 |
29%
downside
| Equal-Weight |
5 May ‘25
4 months ago |
|
10
Maravai LifeSciences
MRVI
$385M
| $2.66 | $5 |
88%
upside
| Equal-Weight |
25 Mar ‘25
5 months ago |
|
|
GRAL
11
GRAIL, Inc. Common Stock
GRAL
$1.35B
| $37.53 | $20 |
47%
downside
| Equal-Weight |
18 Mar ‘25
5 months ago |
|
12
Natera
NTRA
$24.2B
| $176.37 | $185 |
5%
upside
| Overweight |
5 Mar ‘25
6 months ago |
|
13
IQVIA
IQV
$32.2B
| $189.64 | $250 |
32%
upside
| Overweight |
11 Feb ‘25
7 months ago |
|
14
Thermo Fisher Scientific
TMO
$182B
| $482.41 | $678 |
41%
upside
| Overweight |
31 Jan ‘25
7 months ago |
|
15
Stevanato
STVN
$7.25B
| $26.55 | $23 |
13%
downside
| Equal-Weight |
3 Dec ‘24
9 months ago |
|
16
Veracyte
VCYT
$2.52B
| $31.99 | $28 |
12%
downside
| Underweight |
18 Nov ‘24
9 months ago |
|
17
Myriad Genetics
MYGN
$649M
| $6.97 | $21 |
201%
upside
| Equal-Weight |
18 Nov ‘24
9 months ago |
|
18
Pacific Biosciences
PACB
$393M
| $1.31 | $2 |
53%
upside
| Equal-Weight |
12 Aug ‘24
1 year ago |
|
19
Ginkgo Bioworks
DNA
$637M
| $10.76 | $40 |
272%
upside
| Equal-Weight |
15 May ‘24
1 year ago |
|
20
Nautilus Biotechnolgy
NAUT
$84.6M
| $0.6700 | $6 |
796%
upside
| Equal-Weight |
3 Aug ‘23
2 years ago |
|
21
SOPHiA GENETICS
SOPH
$220M
| $3.26 | $10 |
207%
upside
| Overweight |
10 May ‘23
2 years ago |
|
22
Rapid Micro Biosystems
RPID
$118M
| $2.67 | $2.75 |
3%
upside
| Equal-Weight |
7 Mar ‘23
2 years ago |
|
23
Personalis
PSNL
$478M
| $5.39 | $5 |
7%
downside
| Equal-Weight |
27 Feb ‘23
2 years ago |
|
24
Seer Inc
SEER
$114M
| $2.02 | $10 |
395%
upside
| Equal-Weight |
21 Feb ‘23
2 years ago |
|
25
Guardant Health
GH
$7.41B
| $59.44 | $73 |
23%
upside
| Overweight |
21 Feb ‘23
2 years ago |
|